Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa

被引：41
|
作者：
Dinh, Aurelien [1 ]
Wyplosz, Benjamin [2 ]
Kerneis, Solen [3 ]
Lebeaux, David [4 ]
Bouchand, Frederique [5 ]
Duran, Clara [1 ]
Beraud, Guillaume [6 ]
Lazaro, Pauline [7 ]
Davido, Benjamin [1 ]
Henard, Sandrine [8 ]
Canoui, Etienne [3 ]
Ferry, Tristan [9 ]
Wolff, Michel [10 ]
机构：
[1] Versailles St Quentin Univ, Raymond Poincare Univ Hosp, AP HP, Infect Dis Unit, 104 Bd R Poincare, F-92380 Garches, France
[2] Bicetre Univ Hosp, AP HP, Infect Dis Unit, Le Kremlin Bicetre, France
[3] Cochin Univ Hosp, AP HP, Infect Dis Unit, Paris, France
[4] Paris Descartes Univ, Hop Europeen Georges Pompidou, AP HP, Clin Microbiol Mobile Unit, Paris, France
[5] Versailles St Quentin Univ, Raymond Poincare Univ Hosp, AP HP, Dept Pharm, Garches, France
[6] Univ Poitiers Hosp, Infect Dis Unit, Poitiers, France
[7] Univ Poitiers Hosp, Dept Pharm, Poitiers, France
[8] Nancy Univ Hosp, Infect Dis Unit, Nancy, France
[9] Lyon Univ Hosp, Infect Dis Unit, Lyon, France
[10] Hop Xavier Bichat, AP HP, Intens Care & Infect Dis, Paris, France
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 49卷 / 06期
关键词：
DOUBLE-BLIND;
D O I：
10.1016/j.ijantimicag.2017.04.001
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：782 / 783
页数：2
相关论文
共 50 条
  • [1] Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report
    Yuta Ibe
    Ryuichiro Kakizaki
    Hirotoshi Inamura
    Tomoyuki Ishigo
    Yoshihiro Fujiya
    Hiroyuki Inoue
    Shuji Uemura
    Satoshi Fujii
    Satoshi Takahashi
    Eichi Narimatsu
    Masahide Fukudo
    Journal of Pharmaceutical Health Care and Sciences, 9
  • [2] Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report
    Ibe, Yuta
    Kakizaki, Ryuichiro
    Inamura, Hirotoshi
    Ishigo, Tomoyuki
    Fujiya, Yoshihiro
    Inoue, Hiroyuki
    Uemura, Shuji
    Fujii, Satoshi
    Takahashi, Satoshi
    Narimatsu, Eichi
    Fukudo, Masahide
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2023, 9 (01)
  • [3] Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa
    Mogyorodi, Bence
    Cseko, Andras B.
    Hermann, Csaba
    Gal, Janos
    Ivanyi, Zsolt D.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa
    Bence Mogyoródi
    András B. Csékó
    Csaba Hermann
    János Gál
    Zsolt D. Iványi
    Scientific Reports, 12
  • [5] Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes
    Dietl, B.
    Sanchez, I.
    Arcenillas, P.
    Cuchi, E.
    Gomez, L.
    Gonzalez de Molina, F. J.
    Boix-Palop, L.
    Nicolas, J.
    Calbo, E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (03) : 498 - 502
  • [6] Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa
    Gelfand, Michael S.
    Cleveland, Kerry O.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (05) : 853 - U207
  • [7] Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy
    Fernandez-Esgueva, Marta
    Isabel Lopez-Calleja, Ana
    Mulet, Xavier
    Fraile-Ribot, Pablo A.
    Cabot, Gabriel
    Huarte, Rafael
    Rezusta, Antonio
    Oliver, Antonio
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2020, 38 (10): : 474 - 478
  • [8] Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature
    Marianna Meschiari
    Iacopo Franconi
    Erica Bacca
    Vincenzo Bianco
    Gabriella Orlando
    Gianluca Cuomo
    Andrea Bedini
    Cristina Mussini
    Infection, 2021, 49 : 549 - 553
  • [9] Clinical experience with ceftolozane/tazobactam in patients with serious infections due to resistant Pseudomonas aeruginosa
    Xipell, Marc
    Paredes, Sandra
    Fresco, Leticia
    Bodro, Marta
    Marco, Francesc
    Martinez, J. A.
    Soriano, Alex
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 13 : 165 - 170
  • [10] Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections
    Dana J. Holger
    Nicholas S. Rebold
    Sara Alosaimy
    Taylor Morrisette
    Abdalhamid Lagnf
    Ana Christine Belza
    Ashlan J. Kunz Coyne
    Amer El Ghali
    Michael P. Veve
    Michael J. Rybak
    Infectious Diseases and Therapy, 2022, 11 : 1965 - 1980
12345